HemaXis blood collection devices use advanced microfluidic technology to dramatically increase the diagnostic potential of the dried blood format with the following capabilities:
Extraction of ultra pure plasma and serum
Precise volume control
Standardization and reliability
Our first generation device, HemaXis DB incorporates a microfluidic chip with a standard filter card and a protective case to provide a practical solution for whole blood collection at the fingertip that can be performed by anyone, anywhere and at anytime.
MICROFLUIDIC CHIP
– Core technology enabling easy blood collection by the user
– Ensures standardization of samples by accurately and precisely controlling blood volume
FILTER CARD
– Allows blood samples to be transported and stored at room temperatures in a dry format
– Standard filter card fully compatible with automated handling process at lab
PROTECTIVE CASE
– Facilitates easy handling during transfer of blood from microfluidic chip to filter card
– Credit card sized cover secures and protects samples
Building on the advantages of HemaXis DB , HemaXis DP produces ultra pure plasma or serum without the use of a centrifuge, filtration membrane or pump. DBS System’s patented microfluidic technology passively and efficiently separates plasma or serum from whole blood with no hemolysis. This new technology promises to vastly expand the testing potential of micro blood samples.
HemaXis DP will be available Q4, 2017. Preliminary tests of the prototype carried out together with our research partners have confirmed the potential in circulating bio-markers detection, especially within proteomic, metabolomic or clinical chemistry analyses.
Register with us or connect with us on LinkedIn to be updated on the progress of HemaXis DP.